Page last updated: 2024-11-03

praziquantel and Degenerative Diseases, Central Nervous System

praziquantel has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

azinox: Russian drug

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gasparotto, J1
Senger, MR1
Telles de Sá Moreira, E1
Brum, PO1
Carazza Kessler, FG1
Peixoto, DO1
Panzenhagen, AC1
Ong, LK1
Campos Soares, M1
Reis, PA1
Schirato, GV1
Góes Valente, WC1
Araújo Montoya, BO1
Silva, FP1
Fonseca Moreira, JC1
Dal-Pizzol, F1
Castro-Faria-Neto, HC1
Gelain, DP1

Other Studies

1 other study available for praziquantel and Degenerative Diseases, Central Nervous System

ArticleYear
Neurological impairment caused by Schistosoma mansoni systemic infection exhibits early features of idiopathic neurodegenerative disease.
    The Journal of biological chemistry, 2021, Volume: 297, Issue:2

    Topics: Acetylcysteine; Animals; Anthelmintics; Astrocytes; Deferoxamine; Disease Models, Animal; Free Radic

2021